TRANSCATHETER AORTIC VALVE IMPLANTATION
Clinical trials for TRANSCATHETER AORTIC VALVE IMPLANTATION explained in plain language.
Never miss a new study
Get alerted when new TRANSCATHETER AORTIC VALVE IMPLANTATION trials appear
Sign up with your email to follow new studies for TRANSCATHETER AORTIC VALVE IMPLANTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New heart valve device shows promise for High-Risk patients
Disease control OngoingThis study looks at how well the ALLEGRA TAVI system works in real-world patients with severe aortic valve disease who are at high risk for surgery. Researchers tracked 346 patients to see if the device improves survival and quality of life. The goal is to control the disease and…
Matched conditions: TRANSCATHETER AORTIC VALVE IMPLANTATION
Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
New heart valve device under study for severe aortic stenosis patients
Disease control TerminatedThis study is testing a new heart valve system (ALLEGRA Plus) in 177 people with severe aortic stenosis or a failed surgical valve. The goal is to see if the device is safe and works well. Participants will be followed for 12 months to check for death or stroke, and to see if the…
Matched conditions: TRANSCATHETER AORTIC VALVE IMPLANTATION
Phase: NA • Sponsor: NVT GmbH • Aim: Disease control
Last updated Jun 18, 2026 11:48 UTC